Full Year 2021 Aspen Pharmacare Holdings Ltd Earnings Call Transcript
Good morning, everyone, and welcome to Aspen's results presentation for the year ended 30 June 2021. Thanks so much for joining us.
I'm going to begin the presentation. Please take note of the disclaimer and the disclosure notes at the beginning of the presentation. But now let's move to the presentation in detail, and I'm going to kick off with the financial review.
If you look at the financial highlights from continuing operations for the year, it's been a really good year for Aspen: we've had solid double-digit organic growth in our revenue, that's been backed up by really sound growth in earnings; a sharp downtrend in our debt to very much lower leverage levels; a reinstatement of our dividend at ZAR 2.62 cents a share. And all in all, a really satisfying year because we have delivered on the strategy we've set for ourselves and communicated with the market. And it has been a year that we've achieved much, a lot of which is reflected in these results and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
